{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Drug Slows Progression in Refractory HER2+ Breast Cancer ((Non-Physician Credit))

Activity Steps

1 Activity
2 Take Test 3Certificate

Description

The certificate for this activity is for NON-PHYSICIANS.

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Purpose of Activity

To provide information on the results of the HER2CLIMB trial.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify the indication for and potential toxicities from tucatinib.
  2. Evaluate results from the HER2CLIMB trial related to progression-free survival and overall survival with the use of tucatinib.

Disclosures

The author(s), faculty, staff, and planners, including spouses/partners (if any), in any position to control the content of this activity, have disclosed that they have no financial relationships with, or financial interests in, any commercial companies relevant to this educational activity.

Price: $10.00

Credits:

  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planner
Professions: Physician
Test Code: OTN0420
Published: April 2020
Expires: 1/1/2026
Sources: Oncology Times
Required Passing Score: 7/10 (70%)
Authors: Peter M. Goodwin
Categories: Hematology , Oncology
Specialties: Hematology, Oncology
Topics: Breast Cancer